Charleson S. Bell

Charleson is a PhD candidate at Vanderbilt University's biomedical engineering program. The culmination of Charleson’s previous studies in low analyte detection of cancer biomarkers and the fabrication of novel nanoparticles with his current studies regarding the treatment of multi-drug resistant bacteria, lead him to devise the technology behind BioNanovations’ diagnostic strategy.